NRD
Nebula Research & Development’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $749K | Buy |
+961
| New | +$749K | 0.06% | 506 |
|
|
2025
Q1 | – | Sell |
-4,097
| Closed | -$3.16M | – | 1056 |
|
|
2024
Q4 | $3.16M | Buy |
4,097
+1,638
| +67% | +$1.26M | 0.37% | 35 |
|
|
2024
Q3 | $2.18M | Buy |
+2,459
| New | +$2.18M | 0.26% | 84 |
|
|
2024
Q1 | – | Sell |
-2,621
| Closed | -$1.53M | – | 873 |
|
|
2023
Q4 | $1.53M | Buy |
2,621
+1,821
| +228% | +$1.06M | 0.46% | 24 |
|
|
2023
Q3 | $430K | Buy |
+800
| New | +$430K | 0.23% | 165 |
|
|
2023
Q2 | – | Sell |
-869
| Closed | -$298K | – | 399 |
|
|
2023
Q1 | $298K | Buy |
+869
| New | +$298K | 0.53% | 109 |
|